Code 64B15-14.004) Before prescribing any anti-obesity medication: Document BMI 30, or 25 with obesity-related comorbidity (diabetes, hypertension, dyslipidemia, sleep apnea) Conduct or document a comprehensive exam (can be delegated to an APRN/PA under your supervision) Rule out secondary causes (hypothyroidism, Cushings, etc.) Obtain written informed consent and provide Floridas Weight-Loss Consumer Bill of Rights Schedule follow-ups at least every 3 months for patients on continuous therapy Check the PDMP (E-FORCSE) before each controlled substance prescription Enforcement: Florida is serious about this
What concentrations do compounded semaglutide and tirzepatide vials come in
Clinical Results : Participants in STEP trials lost an average of 14.9% body weight over 68 weeks
For example, if you have thyroid cancer and another condition, like anxiety or major depression, then those medical conditions could combine together to equal the listing
Additionally, attempts to remove amyloid- have not halted the progression of neurodegeneration
Mixing them creates stability and degradation risks that eliminate the clinical benefit of either compound